The reductions in leptin, particularly in individuals with obesity, could potentially influence satiety-related pathways, although this hypothesis requires confirmation in studies directly assessing appetite and energy intake. The gene discussed is LEP; the disease is obesity due to melanocortin 4 receptor deficiency.